HUTCHMED DRC

Company Profile

HUTCHMED DRC had its IPO on 2016-03-17 under the ticker symbol HCM.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. HUTCHMED DRC has a staff strength of 1,280 employees.

Stock update

Shares of HUTCHMED DRC opened at $12.63 at the start of the last trading session i.e. 2023-06-02.

The stocks traded within a range of $12.28 - $12.66, and closed at $12.5.

This is a +3.05% increase from the previous day's closing price.

A total volume of 51,896 shares were traded at the close of the day’s session.

In the last one week, shares of HUTCHMED DRC have slipped by -2.5%.

HUTCHMED DRC's Key Ratios

HUTCHMED DRC has a market cap of $2.18 billion, indicating a price to book ratio of 3.0277 and a price to sales ratio of 5.9678.

In the last 12-months HUTCHMED DRC’s revenue was $426.41 million with a gross profit of $-271587000 and an EBITDA of $-399028992. The EBITDA ratio measures HUTCHMED DRC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, HUTCHMED DRC’s operating margin was -95.61% while its return on assets stood at -21.22% with a return of equity of -43%.

In Q4, HUTCHMED DRC’s quarterly earnings growth was a positive 0% while revenue growth was a positive 12.9%.

HUTCHMED DRC’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-2.14 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into HUTCHMED DRC’s profitability.

HUTCHMED DRC stock is trading at a EV to sales ratio of 4.1435 and a EV to EBITDA ratio of -6.3845. Its price to sales ratio in the trailing 12-months stood at 5.9678.

HUTCHMED DRC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$1.03 billion

Total Liabilities

$353.90 million

Operating Cash Flow

$0

Capital Expenditure

$9.35 million

Dividend Payout Ratio

0%

HUTCHMED DRC ended 2023 with $1.03 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.03 billion while shareholder equity stood at $610.37 million.

HUTCHMED DRC ended 2023 with $0 in deferred long-term liabilities, $353.90 million in other current liabilities, 86478000.00 in common stock, $-971481000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $313.28 million and cash and short-term investments were $631.00 million. The company’s total short-term debt was $264,621,000 while long-term debt stood at $18.10 million.

HUTCHMED DRC’s total current assets stands at $839.89 million while long-term investments were $0 and short-term investments were $317.72 million. Its net receivables were $97.99 million compared to accounts payable of $71.12 million and inventory worth $56.69 million.

In 2023, HUTCHMED DRC's operating cash flow was $0 while its capital expenditure stood at $9.35 million.

Comparatively, HUTCHMED DRC paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$12.5

52-Week High

$21.28

52-Week Low

$7.39

Analyst Target Price

$46.7473

HUTCHMED DRC stock is currently trading at $12.5 per share. It touched a 52-week high of $21.28 and a 52-week low of $21.28. Analysts tracking the stock have a 12-month average target price of $46.7473.

Its 50-day moving average was $14.3 and 200-day moving average was $13.51 The short ratio stood at 8.91 indicating a short percent outstanding of 0%.

Around 41.3% of the company’s stock are held by insiders while 1687.5% are held by institutions.